Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia
Clinical trial NCT02146924 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02146924
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-16
- Primary completion
- 2027-06-17
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.